Karolinska Development AB Release: Pharma Portfolio Company Announces FDA 510(K) Clearance For Marketing Of OSSDSIGN Cranial For Sale In The U.S.A.

By January 19, 2017 BioPharma No Comments

  Life Sciences Jobs   …
Source: BioSpace